During his term as president of the American Association of Immunologists, Dr. Gary Koretzky '78, vice provost for academic integration at Cornell, aims to improve science advocacy, public outreach and more.
According to a new study from researchers at Weill Cornell, COVID-19 may bring high risks of severe disease and death in many patients by disrupting key metabolic signals and thereby triggering hyperglycemia.
A team of researchers has profiled in unprecedented detail thousands of individual cells sampled from patients’ brain tumors. The findings, along with the methods developed to obtain those findings, represent a significant advance in cancer research.
A new graduate fellowship program will support students from Minority Serving Institutions (MSIs) to become next-generation leaders in global crop improvement.
The collaborative nature of innovation was one of the key messages author Steven Johnson delivered during a campus visit Sept. 22, as a guest of the Milstein Program in Technology & Humanity.
Cornell is one of only seven institutions across the U.S. that will receive a funding award from the National Institutes of Health through a program aimed at increasing minority faculty in the biomedical sciences.
On Sept. 24, after a year highlighted by so many virtual events, the Class of 2024 finally celebrated their medical school journey with a White Coat Ceremony – hosted in-person.
Students living on campus have a new resource for support when they are experiencing distress, with the launch of the university’s Community Response Team at the start of this semester.
In this Q&A, Dr. Roy Gulick of Weill Cornell Medicine breaks down the science underlying booster shots of COVID-19 vaccines and answers some frequently asked questions.
